Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol
Introduction Osteonecrosis (ON) is characterised by the destruction of the normal blood supply to the bone tissue. ON is the main cause of disability in patients with systemic lupus erythematosus (SLE). Studies have reported the existence of many risk factors for SLE complicated by ON, including the...
Main Authors: | Fei Gao, Meng Zhou, Zhihan Chen, Qijiao Wei, Jianwen Liu, Shengli Zhang, He Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/7/e046163.full |
Similar Items
-
Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01) -
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01) -
Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
by: Creso Abreu Falcão, et al.
Published: (2002-09-01) -
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Published: (2019) -
Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
by: Elena Monzón Manzano, et al.
Published: (2020-10-01)